

HY-120181 · 1 mg
MedChemExpress · Cat: HY-120181
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/agi-14100.htmlDescription
AGI-14100 is a metabolically stable and orally available mIDH1 inhibitor IC50=6 nM . The pharmacochemical optimization of AGI-14100 is aimed at eliminating hPXR activation, resulting in the final drug candidate AG-120. AG-120 can be used in the study of cancers carrying IDH1 mutations. The discovery and development of AGI-14100 can be used for further studies of mutant isocitrate dehydrogenase 1 mIDH1 inhibitors.







